4
Views
17
CrossRef citations to date
0
Altmetric
Review Article

A Review of Mucosal Protection by Synthetic Prostaglandin E Analogs Against Injury by Nonsteroidal Anti-Inflammatory Agents

Pages 36-43 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Russell I. Heigh. (1994) Use of NSAIDs. Postgraduate Medicine 96:6, pages 63-68.
Read now
J. Stachura, J. W. Konturek, A. Dembinski & W. Domschke. (1994) Do Infiltrating Leukocytes Contribute to the Adaptation of Human Gastric Mucosa to Continued Aspirin Administration?. Scandinavian Journal of Gastroenterology 29:11, pages 966-972.
Read now
J. W. Konturek, A. Dembinski, R. Stoll, M. Konturek & W. Domschke. (1993) Gastric Mucosal Blood Flow and Neutrophil Activation in Aspirin-Induced Gastric Mucosal Damage in Man. Scandinavian Journal of Gastroenterology 28:9, pages 767-771.
Read now
S. J. Konturek, N. Kwiecien, E. Sito, W. Obtulowicz, K. Kaminski & J. Oleksy. (1993) Effects of Ebrotidine on Aspirin-Induced Gastric Mucosal Damage and Blood Flow in Humans. Scandinavian Journal of Gastroenterology 28:12, pages 1047-1050.
Read now

Articles from other publishers (13)

Massimo Montalto, Valentina Curigliano, Luca Santoro, Mariaelena Lombardi, Marcello Covino, Giovanni Cammarota, Sara Dalvai, Ferruccio D??Onofrio, Antonio Gasbarrini & Giovanni Gasbarrini. (2006) Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. European Journal of Gastroenterology & Hepatology 18:9, pages 965-967.
Crossref
Jana L. Cargile, James A. Burrow, Inyoung Kim, Noah D. Cohen & A.M. Merritt. (2008) Effect of Dietary Corn Oil Supplementation on Equine Gastric Fluid Acid, Sodium, and Prostaglandin E 2 Content before and during Pentagastrin Infusion . Journal of Veterinary Internal Medicine 18:4, pages 545-549.
Crossref
FISCHER, BECKER, BOKNIK, HUBER, LÜSS, NEUMANN, SCHMITZ, DOMSCHKE & KONTUREK. (1999) Expression of endothelial cell-derived nitric oxide synthase (eNOS) is increased during gastric adaptation to chronic aspirin intake in humans. Alimentary Pharmacology & Therapeutics 13:4, pages 507-514.
Crossref
Michael A. Fiedler & Chuck Biddle. (1998) Review of Chemical, Medication, and Anesthesia Toxicity in the OR. AORN Journal 67:2, pages 398-411.
Crossref
Roshan M. Bashir & Firas H. Al-Kawas. (1996) Rare Causes of Occult Small Intestinal Bleeding, Including Aortoenteric Fistulas, Small Bowel Tumors, and Small Bowel Ulcers. Gastrointestinal Endoscopy Clinics of North America 6:4, pages 709-738.
Crossref
J. Stachura, J. W. Konturek, A. Dembinski & W. Domschke. (1996) Growth Markers in the Human Gastric Mucosa During Adaptation to Continued Aspirin Administration. Journal of Clinical Gastroenterology 22:4, pages 282-287.
Crossref
Cara L Crinnion & Gary M McCart. (2016) Misoprostol for Tinnitus. Annals of Pharmacotherapy 29:7-8, pages 782-784.
Crossref
Jerzy Stachura, Stanisław J. Konturek, Tomasz Brzozowski, Jan Konturek & Wolfram Domschke. (1995) Pathologic basis of gastric mucosal adaptation to topical injury. Journal of Gastroenterology 30:3, pages 416-427.
Crossref
J W Konturek, A Dembinski, R Stoll, W Domschke & S J Konturek. (1994) Mucosal adaptation to aspirin induced gastric damage in humans. Studies on blood flow, gastric mucosal growth, and neutrophil activation.. Gut 35:9, pages 1197-1204.
Crossref
N. HUDSON, F. E. MURRAY, A. T. COLE, G. M. TURNBULL, S. LETTIS & C. J. HAWKEY. (2007) Ranitidine bismuth citrate and aspirin-induced gastric mucosal injury. Alimentary Pharmacology & Therapeutics 7:5, pages 515-521.
Crossref
F. von Bruchhausen, S. Ebel, E. Hackenthal, G. Dannhardt, A. W. Frahm, U. Holzgrabe, K. Keller, E. Nürnberg, H. Rimpler, G. Schneider, P. Surmann, H. U. Wolf & G. Wurm. 1993. Hagers Handbuch der Pharmazeutischen Praxis. Hagers Handbuch der Pharmazeutischen Praxis 787 1056 .
Frank L. Lanza. 1992. Side-Effects of Anti-Inflammatory Drugs 3. Side-Effects of Anti-Inflammatory Drugs 3 64 68 .
W. W. Buchanan & P. M. Brooks. 1991. Prognosis in the Rheumatic Diseases. Prognosis in the Rheumatic Diseases 403 450 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.